Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Ятрогенный химеризм у пациентки с анемией Фанкони и задержкой полового развития
DOI: 10.26442/20795696.2020.2.200108
________________________________________________
Kumykova Z.Kh., Kiseleva I.A., Batyrova Z.K., Buyanovskaya O.A. Iatrogenic chimerism in a patient with Fanconi anemia and delayed puberty. Gynecology. 2020; 22 (2): e. 35. DOI: 10.26442/20795696.2020.2.200108
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Ключевые слова: задержка полового развития, анемия Фанкони, ятрогенный химеризм.
________________________________________________
The article presents a clinical case of delayed puberty in a 13-year-old girl with Fanconi anemia who was sent to the Department of gynecology of children and adolescents for removal of the sexual glands due to the detection of a Y-chromosome in the karyotype at the place of residence. A personalized multidisciplinary approach to the management of a patient with Fanconi anemia with the presence of the Y-chromosome in the karyotype against the background of delayed puberty allowed to identify iatrogenic chimerism and avoid unjustified castration.
Key words: delayed puberty, Fanconi anemia, iatrogenic chimerism.
2. Shimamura A, Alter BP. Pathophysiology and management of inherited bone marrow failure syndromes. Blood Rev 2010; 24 (3): 101–22.
3. Alter BP, Giri N, Savage SA, Rosenberg PS. Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up. Haematologica 2018; 103 (1): 30–9.
4. Rodriguez A, D'Andrea A. Fanconi anemia pathway. Curr Biol 2017; 27 (18): R986-r8.
5. McCann S, Lawler M. Mixed chimerism; detection and significance following BMT. Bone Marrow Translant 1993; 11: 91–4.
6. Tippet P. Blood group chimeras: A review. Vox Sang 1983; 44: 333–59.
7. Bader P, Niethammer D, Willasch A et al. How and when should we monitor chimerism after allogeneic stem cell transplantation? Bone Marrow Transplant 2005; 35 (2): 107–19.
________________________________________________
1. Fiesco-Roa MO, Giri N, McReynolds LJ et al. Genotypephenotype associations in Fanconi anemia: A literature review. Blood Rev 2019; 37. https://doi.org/10.1016/j.blre.2019.100589
2. Shimamura A, Alter BP. Pathophysiology and management of inherited bone marrow failure syndromes. Blood Rev 2010; 24 (3): 101–22.
3. Alter BP, Giri N, Savage SA, Rosenberg PS. Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up. Haematologica 2018; 103 (1): 30–9.
4. Rodriguez A, D'Andrea A. Fanconi anemia pathway. Curr Biol 2017; 27 (18): R986-r8.
5. McCann S, Lawler M. Mixed chimerism; detection and significance following BMT. Bone Marrow Translant 1993; 11: 91–4.
6. Tippet P. Blood group chimeras: A review. Vox Sang 1983; 44: 333–59.
7. Bader P, Niethammer D, Willasch A et al. How and when should we monitor chimerism after allogeneic stem cell transplantation? Bone Marrow Transplant 2005; 35 (2): 107–19.
ФГБУ «Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова» Минздрава России, Москва, Россия
*zai-kumykova@yandex.ru
________________________________________________
Zaira Kh. Kumykova*, Irina A. Kiseleva, Zalina K. Batyrova, Olga A. Buyanovskaya
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Moscow, Russia
*zai-kumykova@yandex.ru